Fabry disease prevalence in patients with familial Mediterranean fever: A cohort study
Keywords:
Alpha-galactosidase, Fabry disease, Familial Mediterranean feverAbstract
Downloads
References
Germain DP. Fabry disease. Orphanet J Rare Dis. 2010;22(5):30. doi: 10.1186/1750-1172-5-30.
Bishop DF, Kornreich R, Desnick RJ. Structural organization of the human alpha-galactosidase A gene: further evidence for the absence of a 3' untranslated region. Proc Natl Acad Sci U S A. 1988;85(11):3903-7. doi: 10.1073/pnas.85.11.3903.
Branton MH, Schiffmann R, Sabnis SG, Murray GJ, Quirk JM, Altarescu G, et al. Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course. Medicine (Baltimore). 2002;81(2):122-38. doi: 10.1097/00005792-200203000-00003.
Meikle PJ, Hopwood JJ, Clague AE, Carey WF. Prevalence of lysosomal storage disorders. JAMA. 1999;281(3):249-54. doi: 10.1001/jama.281.3.249.
Houge G, Skarbøvik AJ. Fabrys sykdom--en diagnostisk og terapeutisk utfordring [Fabry disease--a diagnostic and therapeutic challenge]. Tidsskr Nor Laegeforen. 2005;125(8):1004-6.
Mehta A, Ricci R, Widmer U, Dehout F, Garcia de Lorenzo A, Kampmann C, et al. Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest. 2004;34(3):236-42. doi: 10.1111/j.1365-2362.2004.01309.x.
Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med. 1967;43(2):227-53. doi: 10.1016/0002-9343(67)90167-2.
Ben-Chetrit E, Touitou I. Familial mediterranean Fever in the world. Arthritis Rheum. 2009;61(10):1447-53. doi: 10.1002/art.24458.
Heller H, Gafni J, Michaeli D, Shahin N, Sohar E, Ehrlich G, et al. The arthritis of familial Mediterranean fever (FMF). Arthritis Rheum. 1966 Feb;9(1):1-17. doi: 10.1002/art.1780090102.
Drenth JP, van der Meer JW. Hereditary periodic fever. N Engl J Med. 2001;345(24):1748-57. doi: 10.1056/NEJMra010200.
Yavuzbilge G, Okuyucu M, Civil Y, Günaydın S, Avcı B. Assessment of serum TWEAK levels in patients with familial Mediterranean fever. J Surg Med. 2021;5(2):140-3. doi: 10.28982/josam.833593
Ozdogan H, Ugurlu S. Familial Mediterranean Fever. Switzerland: Springer International Publishing: Chapter 9. The Emerging Treatment in Familial Mediterranean: 2015:137-58.
Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 1997;40(10):1879-85. doi: 10.1002/art.1780401023.
Tumgor G, El C, Bucak IH, Yilmaz M. Association of Familial Mediterranean Fever and Crohns disease. Dicle Med J. 2013;40:301-3. doi: 10.5798/diclemedj.0921.2013.02.0275
Alghamdi M. Familial Mediterranean fever, review of the literature. Clin Rheumatol. 2017;36(8):1707-13. doi: 10.1007/s10067-017-3715-5. Epub 2017 Jun 18.
Monserrat L, Gimeno-Blanes JR, Marín F, Hermida-Prieto M, García-Honrubia A, Pérez I, et al. Prevalence of fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2007;50(25):2399-403. doi: 10.1016/j.jacc.2007.06.062.
Rolfs A, Fazekas F, Grittner U, Dichgans M, Martus P, Holzhausen M, et al. Acute cerebrovascular disease in the young: the Stroke in Young Fabry Patients study. Stroke. 2013;44(2):340-9. doi: 10.1161/STROKEAHA.112.663708. Epub 2013 Jan 10.
Terryn W, Deschoenmakere G, De Keyser J, Meersseman W, Van Biesen W, Wuyts B, et al. Prevalence of Fabry disease in a predominantly hypertensive population with left ventricular hypertrophy. Int J Cardiol. 2013;167(6):2555-60. doi: 10.1016/j.ijcard.2012.06.069.
Elliott P, Baker R, Pasquale F, Quarta G, Ebrahim H, Mehta AB, et al. Prevalence of Anderson-Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson-Fabry Disease survey. Heart. 201;97(23):1957-60. doi: 10.1136/heartjnl-2011-300364.
Zizzo C, Colomba P, Albeggiani G, Gallizzi R, Iemolo F, Nuzzo D, et al. Misdiagnosis of familial Mediterranean fever in patients with Anderson-Fabry disease. Clin Genet. 2013;83(6):576-81. doi: 10.1111/j.1399-0004.2012.01940.x.
Lidove O, Kaminsky P, Hachulla E, Leguy-Seguin V, Lavigne C, Marie I, et al. Fabry disease 'The New Great Imposter': results of the French Observatoire in Internal Medicine Departments (FIMeD). Clin Genet. 2012;81(6):571-7. doi: 10.1111/j.1399-0004.2011.01718.x.
Huzmeli C, Candan F, Alaygut D, Bagci G, Akkaya L, Bagci B, Sozmen EY, Kurtulgan HK, Kayatas M. Prevalence of Fabry Disease in Familial Mediterranean Fever Patients from Central Anatolia of Turkey. Biochem Genet. 2016;54(4):448-456. doi: 10.1007/s10528-016-9731-3.
Niemann M, Rolfs A, Giese A, Mascher H, Breunig F, Ertl G, et al. Lyso-Gb3 Indicates that the Alpha-Galactosidase A Mutation D313Y is not Clinically Relevant for Fabry Disease. JIMD Rep. 2013;7:99-102. doi: 10.1007/8904_2012_154. Epub 2012 Jul 1.
Effraimidis G, Rasmussen ÅK, Bundgaard H, Sørensen SS, Feldt-Rasmussen U. Is the alpha-galactosidase A variant p.Asp313Tyr (p.D313Y) pathogenic for Fabry disease? A systematic review. J Inherit Metab Dis. 2020;43(5):922-33. doi: 10.1002/jimd.12240.
Zompola C, Palaiodimou L, Kokotis P, Papadopoulou M, Theodorou A, Sabanis N, et al. The mutation D313Y may be associated with nervous system manifestations in Fabry disease. J Neurol Sci. 2020;412:116757. doi: 10.1016/j.jns.2020.116757.
Froissart R, Guffon N, Vanier MT, Desnick RJ, Maire I. Fabry disease: D313Y is an alpha-galactosidase A sequence variant that causes pseudodeficient activity in plasma. Mol Genet Metab. 2003;80(3):307-14. doi: 10.1016/S1096-7192(03)00136-7.
Dubuc V, Moore DF, Gioia LC, Saposnik G, Selchen D, Lanthier S. Prevalence of Fabry disease in young patients with cryptogenic ischemic stroke. J Stroke Cerebrovasc Dis. 2013;22(8):1288-92. doi: 10.1016/j.jstrokecerebrovasdis.2012.10.005.
Turkmen K, Guclu A, Sahin G, Kocyigit I, Demirtas L, Erdur FM, et al. Kidney Blood Press Res. 2016;41(6):1016-24. doi: 10.1159/000452605. Epub 2016 Dec 23. PMID: 28006774.
Downloads
- 484 322
Published
Issue
Section
How to Cite
License
Copyright (c) 2022 Sinan Kazan, Elif Dizen Kazan, Onur Tunca, Murat Araz, Sena Ulu
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.